

The company noted that to date it has produced millions of Bi-Level PAP, CPAP and mechanical ventilator devices using the PE-PUR sound abatement foam.

This voluntary recall decision was to address identified potential health risks related to the polyester-based polyurethane (PE-PUR) sound abatement foam component in these devices.Īccording to Philips, majority of the affected devices, which are within the advised five-year service life fall under the first-generation DreamStation product family. Philips yesterday noted that its recall notification was to voluntarily withdraw specific Philips Bi-Level Positive Airway Pressure (Bi-Level PAP), Continuous Positive Airway Pressure (CPAP) and mechanical ventilator devices. Shares of Philips dropped nearly 4% following the announcement. Many of the analysts think that Philips being in a tight spot will lead to a shift in customer demand toward ResMed competitive products. Shares of ResMed RMD rose 6% to reach $231.70 after the company’s peer in the field of sleep apnea devices, Koninklijke Philips PHG issued recall notification for a series of its sleep and respiratory care devices. Institutional Distribution Intelligence.Non-Traditional Exchanges & New Markets.Directors’ and Officers’ Questionnaires.
